61 related articles for article (PubMed ID: 9213768)
1. [Interaction of human immunodeficiency virus reverse transcriptase with oligonucleotide derivatives containing polycyclic aromatic groups at the 5'-terminus].
Zakharova OD; Mart'ianov IV; Timofeeva OA; Sottofattori E; Pyshnyĭ DV; Balbi A; Litvak S; Tarrago-Litvak L; Nevinskiĭ GA
Mol Biol (Mosk); 1997; 31(2):373-9. PubMed ID: 9213768
[No Abstract] [Full Text] [Related]
2. Similarities and differences in the RNase H activities of human immunodeficiency virus type 1 reverse transcriptase and Moloney murine leukemia virus reverse transcriptase.
Gao HQ; Sarafianos SG; Arnold E; Hughes SH
J Mol Biol; 1999 Dec; 294(5):1097-113. PubMed ID: 10600369
[TBL] [Abstract][Full Text] [Related]
3. Analysis of interactions of DNA polymerase beta and reverse transcriptases of human immunodeficiency and mouse leukemia viruses with dNTP analogs containing a modified sugar residue.
Lebedeva NA; Seredina TA; Silnikov VN; Abramova TV; Levina AS; Khodyreva SN; Rechkunova NI; Lavrik OI
Biochemistry (Mosc); 2005 Jan; 70(1):1-7. PubMed ID: 15701045
[TBL] [Abstract][Full Text] [Related]
4. Site-directed mutagenesis of human immunodeficiency virus type 1 reverse transcriptase at amino acid position 138.
Pelemans H; Aertsen A; Van Laethem K; Vandamme AM; De Clercq E; Pérez-Pérez MJ; San-Félix A; Velázquez S; Camarasa MJ; Balzarini J
Virology; 2001 Feb; 280(1):97-106. PubMed ID: 11162823
[TBL] [Abstract][Full Text] [Related]
5. Crystal structures of an N-terminal fragment from Moloney murine leukemia virus reverse transcriptase complexed with nucleic acid: functional implications for template-primer binding to the fingers domain.
Najmudin S; Coté ML; Sun D; Yohannan S; Montano SP; Gu J; Georgiadis MM
J Mol Biol; 2000 Feb; 296(2):613-32. PubMed ID: 10669612
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of feline immunodeficiency virus/human immunodeficiency virus type 1 reverse transcriptase chimeras to non-nucleoside RT inhibitors.
Auwerx J; Esnouf R; De Clercq E; Balzarini J
Mol Pharmacol; 2004 Jan; 65(1):244-51. PubMed ID: 14722257
[TBL] [Abstract][Full Text] [Related]
7. [Derivatives of ddUTP, modified at the 5-position of uridine, as substrate terminators of reverse transcriptase. Hydrolysis of oligonucleotides, terminated by these analogs, by phosphodiesterase I].
D'iachenko LB; Chenchik AA; Lukin MA; Aleksandrova LA; Kraevskiĭ AA; Bibilashvili RSh
Mol Biol (Mosk); 1994; 28(1):102-12. PubMed ID: 7511782
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the stereochemical course of DNA synthesis catalysed by human immunodeficiency virus type 1 reverse transcriptase.
Hopkins S; Furman PA; Painter GR
Biochem Biophys Res Commun; 1989 Aug; 163(1):106-10. PubMed ID: 2476123
[TBL] [Abstract][Full Text] [Related]
9. [Photoaffinity modification of human immunodeficiency virus reverse transcriptase with an analog of deoxyuridine-5'-triphosphate, containing an arylazide group].
Shcherbik NV; Khodyreva SN; Vlasov VA; Dobrikov MI; Dymshits GM; Lavrik OI
Mol Biol (Mosk); 1997; 31(2):344-52. PubMed ID: 9213764
[No Abstract] [Full Text] [Related]
10. Human immunodeficiency virus-reverse transcriptase inhibition and hepatitis C virus RNA-dependent RNA polymerase inhibition activities of fullerene derivatives.
Mashino T; Shimotohno K; Ikegami N; Nishikawa D; Okuda K; Takahashi K; Nakamura S; Mochizuki M
Bioorg Med Chem Lett; 2005 Feb; 15(4):1107-9. PubMed ID: 15686922
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of human T cell leukemia virus type 1 to reverse-transcriptase inhibitors: evidence for resistance to lamivudine.
García-Lerma JG; Nidtha S; Heneine W
J Infect Dis; 2001 Aug; 184(4):507-10. PubMed ID: 11471110
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of HIV-1 reverse transcriptase by defined template/primer DNA oligonucleotides: effect of template length and binding characteristics.
Idriss H; Stammers DK
J Enzyme Inhib; 1994; 8(2):97-112. PubMed ID: 7539076
[TBL] [Abstract][Full Text] [Related]
13. Polycitone A, a novel and potent general inhibitor of retroviral reverse transcriptases and cellular DNA polymerases.
Loya S; Rudi A; Kashman Y; Hizi A
Biochem J; 1999 Nov; 344 Pt 1(Pt 1):85-92. PubMed ID: 10548537
[TBL] [Abstract][Full Text] [Related]
14. Drug targeting of HIV-1 RNA.DNA hybrid structures: thermodynamics of recognition and impact on reverse transcriptase-mediated ribonuclease H activity and viral replication.
Li TK; Barbieri CM; Lin HC; Rabson AB; Yang G; Fan Y; Gaffney BL; Jones RA; Pilch DS
Biochemistry; 2004 Aug; 43(30):9732-42. PubMed ID: 15274628
[TBL] [Abstract][Full Text] [Related]
15. Interaction of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluoro-CTP with human immunodeficiency virus-1 reverse transcriptase and human DNA polymerases: implications for human immunodeficiency virus drug design.
Kukhanova M; Li X; Chen SH; King I; Doyle T; Prusoff W; Cheng YC
Mol Pharmacol; 1998 May; 53(5):801-7. PubMed ID: 9584205
[TBL] [Abstract][Full Text] [Related]
16. Novel methods of generating specific oligonucleotide inhibitors of viral polymerases.
Chen H; Brown D; Gold L
Methods Enzymol; 1996; 275():503-20. PubMed ID: 9026656
[No Abstract] [Full Text] [Related]
17. Evaluation of an oligonucleotide ligation assay for detection of mutations in HIV-1 subtype C individuals who have high level resistance to nucleoside reverse transcriptase inhibitors and non-nucleoside reverse transcriptase inhibitors.
Wallis CL; Mahomed I; Morris L; Chidarikire T; Stevens G; Rekhviashvili N; Stevens W
J Virol Methods; 2005 May; 125(2):99-109. PubMed ID: 15794978
[TBL] [Abstract][Full Text] [Related]
18. Expression of an active form of recombinant Ty1 reverse transcriptase in Escherichia coli: a fusion protein containing the C-terminal region of the Ty1 integrase linked to the reverse transcriptase-RNase H domain exhibits polymerase and RNase H activities.
Wilhelm M; Boutabout M; Wilhelm FX
Biochem J; 2000 Jun; 348 Pt 2(Pt 2):337-42. PubMed ID: 10816427
[TBL] [Abstract][Full Text] [Related]
19. Substitution of Asp114 or Arg116 in the fingers domain of moloney murine leukemia virus reverse transcriptase affects interactions with the template-primer resulting in decreased processivity.
Gu J; Villanueva RA; Snyder CS; Roth MJ; Georgiadis MM
J Mol Biol; 2001 Jan; 305(2):341-59. PubMed ID: 11124910
[TBL] [Abstract][Full Text] [Related]
20. Polymorphism and drug-selected mutations in the reverse transcriptase gene of HIV-2 from patients living in southeastern France.
Colson P; Henry M; Tivoli N; Gallais H; Gastaut JA; Moreau J; Tamalet C
J Med Virol; 2005 Mar; 75(3):381-90. PubMed ID: 15648062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
